Immune-related Adverse Events Associated With Checkpoint Inhibition in the Setting of CAR T Cell Therapy: A Case SeriesSwetha Kambhampati, Charalambos Andreadis, Bita Fakhri et al.|Clinical Lymphoma Myeloma & Leukemia|2019Cited by 24